Discontinuation report MICOZOLE
Report ID | 173736 |
Drug Identification Number | 02231106 |
Brand name | MICOZOLE |
Common or Proper name | MICOZOLE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MICONAZOLE NITRATE |
Strength(s) | 2% |
Dosage form(s) | CREAM |
Route of administration | VAGINAL VAGINAL |
Packaging size | 45G |
ATC code | G01AF |
ATC description | ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST. |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-11-01 |
Remaining supply date | 2022-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-11-04 | English | Compare |
v2 | 2022-11-04 | French | Compare |
Showing 1 to 2 of 2